Idarubicin concentration (μg/ml) | Days after exposure | |||
---|---|---|---|---|
2 | 5 | 7 | 10 | |
0 | 5.5 (0.8) | 5.5 (0.6) | 7.8 (2.8) | 13.0 (0.6) |
0.01 | 4.7 (2.3) | 5.4 (0.6) | 7.4 (0.8) | 13.6 (1.9) |
0.03 | 4.1 (1.1) | 5.1 (1.0) | 7.9 (2.5) | 10.8 (1.0) |
0.1 | 2.5 (0.7) | 3.3 (1.2) | 3.7 (1.9) | 6.6 (3.6) |
0.3 | 1.8 (0.3) | 2.0 (0.2) | 1.9 (0.5) | 2.6 (2.0) |
1 | 1.8 (0) | 1.4 (0.7) | 1.2 (0.5) | 1.6 (0.6) |
2.5 | 2.1 (0.9) | 0.9 (0) | 0.8 (0.1) | 0.7 (0.2) |
5 | 1.6 (0.2) | 0.6 (0.4) | 0.9 (0) | 0.6 (0) |
10 | 1.0 (0) | 0.6 (0.1) | 0.2 (0) | 0.4 (0) |
20 | 0.6 (0.2) | 0.4 (0.2) | 0.3 (0.3) | 0.4 (0.2) |